| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $1,156,712 ) |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | K01DK127150 | Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | 000 | 5 | NIH | 12/6/2023 | $145,229 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL160966 | The mechanisms of cardiac thin filament regulation in health and disease. | 000 | 3 | NIH | 12/21/2023 | $510,187 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R00HD099269 | A-to-I RNA modifications in mouse oocytes | 000 | 5 | NIH | 2/15/2024 | $219,003 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL169253 | Epigenetic Modulation of Cellular Senescence in the Cystic Fibrosis Lung | 000 | 1 | NIH | 3/15/2024 | $645,992 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151702 | Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis | 001 | 4 | NIH | 1/29/2024 | $404,053 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA280570 | Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer. | 000 | 2 | NIH | 4/10/2024 | $166,547 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 00 | 13 | HRSA | 3/13/2024 | $107,811 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 000 | 1 | NIH | 11/20/2023 | $0 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 000 | 4 | NIH | 12/5/2023 | $0 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 001 | 1 | NIH | 11/20/2023 | $0 |
| | 2024 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01MH118139 | Targeting SIV macrophage reservoirs in the CNS by CSF1R inhibition | 001 | 4 | NIH | 12/15/2023 | -$372,119 |
| | 2024 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01MH118139 | Targeting SIV macrophage reservoirs in the CNS by CSF1R inhibition | 000 | 4 | NIH | 12/15/2023 | -$663,991 |
| | 2024 | 2021 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL142129 | Impact of atherosclerosis, metabolic syndrome, and STAT4-dependent immunity on Alzheimer's disease | 001 | 4 | NIH | 12/6/2023 | -$3,012 |
| | 2024 | 2021 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL142129 | Impact of atherosclerosis, metabolic syndrome, and STAT4-dependent immunity on Alzheimer's disease | 000 | 4 | NIH | 12/6/2023 | -$2,717 |
| | 2024 | 2021 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21AI145809 | An Aptamer-Based Biosensor for Point-of-Care Monitoring of Adherence to Oral Tenofovir Antiretroviral Regimens for HIV Prevention and Treatment | 000 | 2 | NIH | 1/8/2024 | -$272 |
|
| Issue Date FY: 2023 ( Subtotal = $8,290,315 ) (Continued on the next page) |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 002 | 4 | NIH | 5/9/2023 | $598,343 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151616 | Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension | 000 | 4 | NIH | 7/7/2023 | $375,000 |
| | 2023 | 2023 | Eastern Virginia Medical School | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | E2614830 | PCL - Allopathic Medicine | 000 | 3 | HRSA | 8/22/2023 | $176,715 |
| | 2023 | 2023 | Eastern Virginia Medical School | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | E3626086 | LDS - Allopathic Medicine | 000 | 3 | HRSA | 8/22/2023 | $165,348 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL160966 | The mechanisms of cardiac thin filament regulation in health and disease. | 000 | 2 | NIH | 12/30/2022 | $521,943 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL160966 | The mechanisms of cardiac thin filament regulation in health and disease. | 001 | 2 | NIH | 3/10/2023 | $57,994 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA287457 | Does Tobacco Social Media Marketing Alter Adolescent Risk Perceptions and Use? Longitudinal Data-Adaptive Estimators and Causal Inference to Enhance Understanding | 000 | 1 | NIH | 9/25/2023 | $210,480 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21HD112742 | Designing effective RNA therapies for oocyte maturation | 000 | 1 | NIH | 8/24/2023 | $412,500 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA280570 | Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer. | 000 | 1 | NIH | 4/24/2023 | $210,375 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01DA054826 | Role of the NLRP3 Inflammasome in Mediating Microglial Activation and Development of Neuropsychiatric Symptoms Induced by HIV, Antiretrovirals and Cocaine | 000 | 3 | NIH | 6/30/2023 | $375,942 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | K01DK127150 | Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | 000 | 4 | NIH | 12/23/2022 | $145,229 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R33AI142685 | Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception | 001 | 5 | NIH | 3/27/2023 | $2,036,799 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U2CCA271894 | Virginia-UCLA-Toronto Biomarker Characterization Center | 001 | 2 | NIH | 8/21/2023 | $827,343 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R00HD099269 | A-to-I RNA modifications in mouse oocytes | 000 | 4 | NIH | 2/16/2023 | $245,717 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 003 | 1 | NIH | 5/23/2023 | $515,775 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 002 | 1 | NIH | 5/23/2023 | $0 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 001 | 1 | NIH | 12/19/2022 | $0 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 000 | 1 | NIH | 10/31/2022 | $525,000 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 01 | 12 | HRSA | 9/26/2023 | $0 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 00 | 12 | HRSA | 3/16/2023 | $431,248 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL150014 | Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes | 000 | 4 | NIH | 5/23/2023 | $449,160 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 004 | 4 | NIH | 6/21/2023 | $24,245 |
| | 2023 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 003 | 4 | NIH | 6/19/2023 | $1 |
| | 2023 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01MH118139 | Targeting SIV macrophage reservoirs in the CNS by CSF1R inhibition | 001 | 4 | NIH | 7/31/2023 | $0 |
| | 2023 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | K01DK127150 | Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | 001 | 3 | NIH | 12/23/2022 | $0 |
| | 2023 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R33AI142685 | Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception | 000 | 4 | NIH | 2/15/2023 | $1,139,271 |
| | 2023 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U2CCA271894 | Virginia-UCLA-Toronto Biomarker Characterization Center | 000 | 1 | NIH | 4/18/2023 | $27,211 |
| | 2023 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | F31NS116926 | Identification and characterization of a new pericyte subset: Role in blood-brain barrier breakdown | 000 | 3 | NIH | 8/14/2023 | $0 |
| | 2023 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 000 | 3 | NIH | 11/18/2022 | $0 |
| | 2023 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01MH118139 | Targeting SIV macrophage reservoirs in the CNS by CSF1R inhibition | 000 | 4 | NIH | 7/31/2023 | $0 |
| | 2023 | 2021 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL139000 | B cell anergy, modified LDL uptake, and atherosclerosis | 000 | 4 | NIH | 3/3/2023 | $0 |
| | 2023 | 2021 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 01 | 10 | HRSA | 3/1/2023 | -$1 |
| | 2023 | 2021 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R61AI142685 | Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception | 001 | 3 | NIH | 2/15/2023 | -$1,052,953 |
|
